These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 439962)
1. Drugs and the liver. Rosenoer VM; Tornay AS Med Clin North Am; 1979 Mar; 63(2):405-12. PubMed ID: 439962 [TBL] [Abstract][Full Text] [Related]
2. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia]. Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901 [TBL] [Abstract][Full Text] [Related]
3. Benign hepatic tumors and oral contraceptive pills. Kalra TM; Mangla JC; DePapp EW Am J Med; 1976 Dec; 61(6):871-7. PubMed ID: 188336 [TBL] [Abstract][Full Text] [Related]
4. Hepatic tumors and oral contraceptives: surgical management. Gonzalez F; Marks C J Surg Oncol; 1985 Jul; 29(3):193-7. PubMed ID: 3001424 [TBL] [Abstract][Full Text] [Related]
5. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1982. Tender hepatomegaly in a 29-year-old woman. N Engl J Med; 1982 Oct; 307(15):934-42. PubMed ID: 7110274 [TBL] [Abstract][Full Text] [Related]
6. Hepatic tumors induced by sex steroids. Mays ET; Christopherson W Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460 [TBL] [Abstract][Full Text] [Related]
7. Possible association between benign hepatomas and oral contraceptives. Baum JK; Bookstein JJ; Holtz F; Klein EW Lancet; 1973 Oct; 2(7835):926-9. PubMed ID: 4126557 [TBL] [Abstract][Full Text] [Related]
9. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. Mettlin C; Natarajan N J Surg Oncol; 1981; 18(1):73-85. PubMed ID: 6270469 [TBL] [Abstract][Full Text] [Related]
10. [Primary malignant tumour of the liver associated with the ingestion of oral contraceptives (author's transl)]. Leclere J; Meot B; Marchal F; Mizrahi R; Collard F; Begue JY; Rauber G; Hartemann P Nouv Presse Med; 1979 Jan; 8(5):346-9. PubMed ID: 233379 [TBL] [Abstract][Full Text] [Related]
11. [Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect]. Hecht Y Contracept Fertil Sex (Paris); 1991 May; 19(5):403-8. PubMed ID: 12316961 [TBL] [Abstract][Full Text] [Related]
12. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)]. Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890 [TBL] [Abstract][Full Text] [Related]
13. [Hepatic changes caused by contraceptive steroids]. Uribe M; de Uribe MH; CarĂo AA Rev Gastroenterol Mex; 1977; 42(3):139-47. PubMed ID: 616980 [TBL] [Abstract][Full Text] [Related]
14. Benign liver cell adenoma associated with use of oral contraceptive agents. Baek S; Sloane CE; Futterman SC Ann Surg; 1976 Mar; 183(3):239-42. PubMed ID: 176959 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and benign tumors of the liver. Fitz JG West J Med; 1984 Feb; 140(2):260-7. PubMed ID: 6730471 [TBL] [Abstract][Full Text] [Related]